UNSPECIFIED ADULT SOLID TUMOR, PROTOCOL SPECIFIC
Clinical trials for UNSPECIFIED ADULT SOLID TUMOR, PROTOCOL SPECIFIC explained in plain language.
Never miss a new study
Get alerted when new UNSPECIFIED ADULT SOLID TUMOR, PROTOCOL SPECIFIC trials appear
Sign up with your email to follow new studies for UNSPECIFIED ADULT SOLID TUMOR, PROTOCOL SPECIFIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New radiation dosing strategy aims to tame large brain metastases
Disease control CompletedThis phase I trial tested a special type of radiation called hypofractionated radiosurgery for people with large brain metastases (tumors that spread from other cancers). The goal was to find the safest and most effective dose while limiting damage to healthy brain tissue. Twenty…
Matched conditions: UNSPECIFIED ADULT SOLID TUMOR, PROTOCOL SPECIFIC
Phase: NA • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New shot could stop chemo sickness in its tracks
Symptom relief CompletedThis phase 3 trial tested a drug called APF530, given as a shot, to prevent nausea and vomiting caused by chemotherapy. Over 1,400 cancer patients took part, comparing APF530 with the standard drug Aloxi. The goal was to see if APF530 could keep patients from vomiting or needing …
Matched conditions: UNSPECIFIED ADULT SOLID TUMOR, PROTOCOL SPECIFIC
Phase: PHASE3 • Sponsor: Heron Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC